nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—ABCC2—epilepsy syndrome	0.325	1	CbGaD
Lomefloxacin—ABCC2—Levetiracetam—epilepsy syndrome	0.104	0.247	CbGbCtD
Lomefloxacin—ABCC2—Carbamazepine—epilepsy syndrome	0.0596	0.142	CbGbCtD
Lomefloxacin—ABCC2—Phenytoin—epilepsy syndrome	0.0534	0.127	CbGbCtD
Lomefloxacin—ABCC2—Phenobarbital—epilepsy syndrome	0.0476	0.114	CbGbCtD
Lomefloxacin—SLC22A5—Valproic Acid—epilepsy syndrome	0.0457	0.109	CbGbCtD
Lomefloxacin—CYP1A2—Carbamazepine—epilepsy syndrome	0.0222	0.0529	CbGbCtD
Lomefloxacin—CYP1A2—Primidone—epilepsy syndrome	0.0207	0.0494	CbGbCtD
Lomefloxacin—CYP1A2—Propofol—epilepsy syndrome	0.0186	0.0443	CbGbCtD
Lomefloxacin—CYP1A2—Phenobarbital—epilepsy syndrome	0.0178	0.0423	CbGbCtD
Lomefloxacin—CYP1A2—Diazepam—epilepsy syndrome	0.0168	0.0401	CbGbCtD
Lomefloxacin—CYP1A2—Valproic Acid—epilepsy syndrome	0.0133	0.0316	CbGbCtD
Lomefloxacin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00214	0.768	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCC2—epilepsy syndrome	0.000463	0.315	CrCbGaD
Lomefloxacin—Ofloxacin—ABCC2—epilepsy syndrome	0.000326	0.222	CrCbGaD
Lomefloxacin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000282	0.101	CbGdCrCtD
Lomefloxacin—Gatifloxacin—ALB—epilepsy syndrome	0.000274	0.186	CrCbGaD
Lomefloxacin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000195	0.0703	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCB1—epilepsy syndrome	0.00017	0.116	CrCbGaD
Lomefloxacin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000168	0.0602	CbGdCrCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RET—epilepsy syndrome	0.000131	0.00683	CbGpPWpGaD
Lomefloxacin—CYP1A2—Xenobiotics—CYP2D6—epilepsy syndrome	0.000128	0.00667	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000123	0.00642	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—UBE3A—epilepsy syndrome	0.000121	0.00631	CbGpPWpGaD
Lomefloxacin—Levofloxacin—ABCB1—epilepsy syndrome	0.00012	0.0816	CrCbGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000119	0.00622	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000116	0.00606	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000116	0.00606	CbGpPWpGaD
Lomefloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000116	0.0788	CrCbGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CHRM1—epilepsy syndrome	0.000116	0.00605	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000115	0.00602	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000115	0.00602	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—KCNMA1—epilepsy syndrome	0.000113	0.0059	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000112	0.00587	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000111	0.00579	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000106	0.00555	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.000106	0.00553	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.000106	0.00551	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.000106	0.00551	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000103	0.0054	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000103	0.00537	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000103	0.00537	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000103	0.00537	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUND—epilepsy syndrome	0.000101	0.00529	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	9.88e-05	0.00516	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MAPK10—epilepsy syndrome	9.68e-05	0.00506	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	9.5e-05	0.00496	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	9.4e-05	0.00491	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CHRNB2—epilepsy syndrome	9.09e-05	0.00475	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	8.7e-05	0.00454	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC6A1—epilepsy syndrome	8.68e-05	0.00453	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	8.66e-05	0.00452	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	8.43e-05	0.0044	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	8.43e-05	0.0044	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	8.4e-05	0.00438	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CRH—epilepsy syndrome	8.26e-05	0.00431	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—COX3—epilepsy syndrome	8.22e-05	0.00429	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	7.79e-05	0.00407	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	7.79e-05	0.00407	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	7.79e-05	0.00407	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SLC6A4—epilepsy syndrome	7.68e-05	0.00401	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—KCNAB2—epilepsy syndrome	7.62e-05	0.00398	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	7.51e-05	0.00392	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	7.51e-05	0.00392	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	7.51e-05	0.00392	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	7.49e-05	0.00391	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	7.43e-05	0.00388	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	7.43e-05	0.00388	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	7.18e-05	0.00375	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PAFAH1B1—epilepsy syndrome	7.17e-05	0.00374	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC6A4—epilepsy syndrome	6.94e-05	0.00362	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	6.87e-05	0.00359	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	6.85e-05	0.00357	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TH—epilepsy syndrome	6.84e-05	0.00357	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—HTR7—epilepsy syndrome	6.72e-05	0.00351	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PAFAH1B1—epilepsy syndrome	6.41e-05	0.00335	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—epilepsy syndrome	6.36e-05	0.00332	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC2A1—epilepsy syndrome	6.28e-05	0.00328	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOD—epilepsy syndrome	6.06e-05	0.00316	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	6.01e-05	0.00314	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	5.97e-05	0.00312	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	5.96e-05	0.00311	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	5.92e-05	0.00309	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	5.9e-05	0.00308	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	5.9e-05	0.00308	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HBEGF—epilepsy syndrome	5.9e-05	0.00308	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	5.89e-05	0.00308	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	5.88e-05	0.00307	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	5.84e-05	0.00305	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	5.81e-05	0.00303	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	5.8e-05	0.00303	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	5.78e-05	0.00302	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	5.71e-05	0.00298	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	5.7e-05	0.00297	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	5.7e-05	0.00297	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	5.7e-05	0.00297	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—AVP—epilepsy syndrome	5.66e-05	0.00295	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	5.63e-05	0.00294	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SIRT1—epilepsy syndrome	5.55e-05	0.0029	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	5.43e-05	0.00284	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	5.43e-05	0.00284	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—APOE—epilepsy syndrome	5.42e-05	0.00283	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	5.41e-05	0.00283	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	5.4e-05	0.00282	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	5.4e-05	0.00282	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	5.4e-05	0.00282	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	5.4e-05	0.00282	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	5.31e-05	0.00277	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	5.24e-05	0.00273	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HMOX1—epilepsy syndrome	5.16e-05	0.0027	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	5.02e-05	0.00262	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	4.82e-05	0.00252	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.8e-05	0.0025	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.79e-05	0.0025	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.77e-05	0.00249	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.72e-05	0.00246	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.59e-05	0.0024	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	4.58e-05	0.00239	CbGpPWpGaD
Lomefloxacin—Asthenia—Oxcarbazepine—epilepsy syndrome	4.52e-05	0.000194	CcSEcCtD
Lomefloxacin—Pruritus—Clonazepam—epilepsy syndrome	4.51e-05	0.000194	CcSEcCtD
Lomefloxacin—Vomiting—Vigabatrin—epilepsy syndrome	4.51e-05	0.000194	CcSEcCtD
Lomefloxacin—Skin disorder—Valproic Acid—epilepsy syndrome	4.5e-05	0.000194	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.48e-05	0.000193	CcSEcCtD
Lomefloxacin—Cough—Pregabalin—epilepsy syndrome	4.48e-05	0.000193	CcSEcCtD
Lomefloxacin—Pruritus—Phenytoin—epilepsy syndrome	4.48e-05	0.000192	CcSEcCtD
Lomefloxacin—Nausea—Levetiracetam—epilepsy syndrome	4.47e-05	0.000192	CcSEcCtD
Lomefloxacin—Rash—Vigabatrin—epilepsy syndrome	4.47e-05	0.000192	CcSEcCtD
Lomefloxacin—Dizziness—Felbamate—epilepsy syndrome	4.46e-05	0.000192	CcSEcCtD
Lomefloxacin—Dermatitis—Vigabatrin—epilepsy syndrome	4.46e-05	0.000192	CcSEcCtD
Lomefloxacin—Pruritus—Oxcarbazepine—epilepsy syndrome	4.45e-05	0.000191	CcSEcCtD
Lomefloxacin—Convulsion—Pregabalin—epilepsy syndrome	4.45e-05	0.000191	CcSEcCtD
Lomefloxacin—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.45e-05	0.000191	CcSEcCtD
Lomefloxacin—Headache—Vigabatrin—epilepsy syndrome	4.44e-05	0.000191	CcSEcCtD
Lomefloxacin—Hypertension—Pregabalin—epilepsy syndrome	4.44e-05	0.000191	CcSEcCtD
Lomefloxacin—Vomiting—Diazepam—epilepsy syndrome	4.44e-05	0.000191	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	4.43e-05	0.00231	CbGpPWpGaD
Lomefloxacin—Anorexia—Valproic Acid—epilepsy syndrome	4.42e-05	0.00019	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.42e-05	0.00231	CbGpPWpGaD
Lomefloxacin—Tremor—Gabapentin—epilepsy syndrome	4.41e-05	0.00019	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	4.41e-05	0.0023	CbGpPWpGaD
Lomefloxacin—Rash—Diazepam—epilepsy syndrome	4.4e-05	0.000189	CcSEcCtD
Lomefloxacin—Dermatitis—Diazepam—epilepsy syndrome	4.39e-05	0.000189	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.39e-05	0.00229	CbGpPWpGaD
Lomefloxacin—Visual impairment—Topiramate—epilepsy syndrome	4.39e-05	0.000189	CcSEcCtD
Lomefloxacin—Arthralgia—Pregabalin—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Myalgia—Pregabalin—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Chest pain—Pregabalin—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Dizziness—Zonisamide—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Headache—Diazepam—epilepsy syndrome	4.37e-05	0.000188	CcSEcCtD
Lomefloxacin—Anxiety—Pregabalin—epilepsy syndrome	4.36e-05	0.000187	CcSEcCtD
Lomefloxacin—Diarrhoea—Clonazepam—epilepsy syndrome	4.36e-05	0.000187	CcSEcCtD
Lomefloxacin—Anaemia—Gabapentin—epilepsy syndrome	4.35e-05	0.000187	CcSEcCtD
Lomefloxacin—Hypotension—Valproic Acid—epilepsy syndrome	4.33e-05	0.000186	CcSEcCtD
Lomefloxacin—Asthenia—Carbamazepine—epilepsy syndrome	4.33e-05	0.000186	CcSEcCtD
Lomefloxacin—Agitation—Gabapentin—epilepsy syndrome	4.33e-05	0.000186	CcSEcCtD
Lomefloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	4.33e-05	0.000186	CcSEcCtD
Lomefloxacin—Discomfort—Pregabalin—epilepsy syndrome	4.32e-05	0.000186	CcSEcCtD
Lomefloxacin—Nausea—Fosphenytoin—epilepsy syndrome	4.32e-05	0.000186	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	4.32e-05	0.00225	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	4.32e-05	0.00225	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.31e-05	0.000185	CcSEcCtD
Lomefloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	4.3e-05	0.000185	CcSEcCtD
Lomefloxacin—Angioedema—Gabapentin—epilepsy syndrome	4.3e-05	0.000185	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	4.3e-05	0.00225	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.3e-05	0.000185	CcSEcCtD
Lomefloxacin—Vomiting—Felbamate—epilepsy syndrome	4.29e-05	0.000185	CcSEcCtD
Lomefloxacin—Dry mouth—Pregabalin—epilepsy syndrome	4.28e-05	0.000184	CcSEcCtD
Lomefloxacin—Pruritus—Carbamazepine—epilepsy syndrome	4.27e-05	0.000184	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.27e-05	0.00223	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.27e-05	0.00223	CbGpPWpGaD
Lomefloxacin—Rash—Felbamate—epilepsy syndrome	4.26e-05	0.000183	CcSEcCtD
Lomefloxacin—Dermatitis—Felbamate—epilepsy syndrome	4.25e-05	0.000183	CcSEcCtD
Lomefloxacin—Malaise—Gabapentin—epilepsy syndrome	4.25e-05	0.000183	CcSEcCtD
Lomefloxacin—Tinnitus—Topiramate—epilepsy syndrome	4.25e-05	0.000182	CcSEcCtD
Lomefloxacin—Vertigo—Gabapentin—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Lomefloxacin—Headache—Felbamate—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Lomefloxacin—Confusional state—Pregabalin—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Lomefloxacin—Flushing—Topiramate—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Lomefloxacin—Syncope—Gabapentin—epilepsy syndrome	4.22e-05	0.000182	CcSEcCtD
Lomefloxacin—Leukopenia—Gabapentin—epilepsy syndrome	4.22e-05	0.000181	CcSEcCtD
Lomefloxacin—Dizziness—Clonazepam—epilepsy syndrome	4.21e-05	0.000181	CcSEcCtD
Lomefloxacin—Nausea—Vigabatrin—epilepsy syndrome	4.21e-05	0.000181	CcSEcCtD
Lomefloxacin—Vomiting—Zonisamide—epilepsy syndrome	4.2e-05	0.000181	CcSEcCtD
Lomefloxacin—Insomnia—Valproic Acid—epilepsy syndrome	4.19e-05	0.00018	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.19e-05	0.00018	CcSEcCtD
Lomefloxacin—Oedema—Pregabalin—epilepsy syndrome	4.19e-05	0.00018	CcSEcCtD
Lomefloxacin—Asthenia—Lamotrigine—epilepsy syndrome	4.19e-05	0.00018	CcSEcCtD
Lomefloxacin—Dizziness—Phenytoin—epilepsy syndrome	4.18e-05	0.00018	CcSEcCtD
Lomefloxacin—Rash—Zonisamide—epilepsy syndrome	4.17e-05	0.000179	CcSEcCtD
Lomefloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	4.16e-05	0.000179	CcSEcCtD
Lomefloxacin—Dermatitis—Zonisamide—epilepsy syndrome	4.16e-05	0.000179	CcSEcCtD
Lomefloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	4.16e-05	0.000179	CcSEcCtD
Lomefloxacin—Nausea—Diazepam—epilepsy syndrome	4.14e-05	0.000178	CcSEcCtD
Lomefloxacin—Loss of consciousness—Gabapentin—epilepsy syndrome	4.14e-05	0.000178	CcSEcCtD
Lomefloxacin—Headache—Zonisamide—epilepsy syndrome	4.14e-05	0.000178	CcSEcCtD
Lomefloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	4.13e-05	0.000178	CcSEcCtD
Lomefloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	4.13e-05	0.000178	CcSEcCtD
Lomefloxacin—Pruritus—Lamotrigine—epilepsy syndrome	4.13e-05	0.000178	CcSEcCtD
Lomefloxacin—Shock—Pregabalin—epilepsy syndrome	4.13e-05	0.000177	CcSEcCtD
Lomefloxacin—Somnolence—Valproic Acid—epilepsy syndrome	4.12e-05	0.000177	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	4.12e-05	0.00215	CbGpPWpGaD
Lomefloxacin—Cough—Gabapentin—epilepsy syndrome	4.11e-05	0.000177	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.11e-05	0.000176	CcSEcCtD
Lomefloxacin—Tachycardia—Pregabalin—epilepsy syndrome	4.09e-05	0.000176	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	4.09e-05	0.00214	CbGpPWpGaD
Lomefloxacin—Chills—Topiramate—epilepsy syndrome	4.09e-05	0.000176	CcSEcCtD
Lomefloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	4.08e-05	0.000175	CcSEcCtD
Lomefloxacin—Convulsion—Gabapentin—epilepsy syndrome	4.08e-05	0.000175	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—NOS2—epilepsy syndrome	4.08e-05	0.00213	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	4.08e-05	0.00213	CbGpPWpGaD
Lomefloxacin—Skin disorder—Pregabalin—epilepsy syndrome	4.07e-05	0.000175	CcSEcCtD
Lomefloxacin—Hypertension—Gabapentin—epilepsy syndrome	4.07e-05	0.000175	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.05e-05	0.000174	CcSEcCtD
Lomefloxacin—Vomiting—Clonazepam—epilepsy syndrome	4.05e-05	0.000174	CcSEcCtD
Lomefloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	4.03e-05	0.000173	CcSEcCtD
Lomefloxacin—Vomiting—Phenytoin—epilepsy syndrome	4.02e-05	0.000173	CcSEcCtD
Lomefloxacin—Rash—Clonazepam—epilepsy syndrome	4.02e-05	0.000173	CcSEcCtD
Lomefloxacin—Dermatitis—Clonazepam—epilepsy syndrome	4.01e-05	0.000172	CcSEcCtD
Lomefloxacin—Chest pain—Gabapentin—epilepsy syndrome	4.01e-05	0.000172	CcSEcCtD
Lomefloxacin—Myalgia—Gabapentin—epilepsy syndrome	4.01e-05	0.000172	CcSEcCtD
Lomefloxacin—Arthralgia—Gabapentin—epilepsy syndrome	4.01e-05	0.000172	CcSEcCtD
Lomefloxacin—Nausea—Felbamate—epilepsy syndrome	4.01e-05	0.000172	CcSEcCtD
Lomefloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	4e-05	0.000172	CcSEcCtD
Lomefloxacin—Fatigue—Valproic Acid—epilepsy syndrome	4e-05	0.000172	CcSEcCtD
Lomefloxacin—Anxiety—Gabapentin—epilepsy syndrome	4e-05	0.000172	CcSEcCtD
Lomefloxacin—Anorexia—Pregabalin—epilepsy syndrome	4e-05	0.000172	CcSEcCtD
Lomefloxacin—Dizziness—Carbamazepine—epilepsy syndrome	3.99e-05	0.000172	CcSEcCtD
Lomefloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	3.99e-05	0.000172	CcSEcCtD
Lomefloxacin—Headache—Clonazepam—epilepsy syndrome	3.99e-05	0.000172	CcSEcCtD
Lomefloxacin—Rash—Phenytoin—epilepsy syndrome	3.99e-05	0.000171	CcSEcCtD
Lomefloxacin—Dermatitis—Phenytoin—epilepsy syndrome	3.99e-05	0.000171	CcSEcCtD
Lomefloxacin—Rash—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000171	CcSEcCtD
Lomefloxacin—Constipation—Valproic Acid—epilepsy syndrome	3.97e-05	0.00017	CcSEcCtD
Lomefloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.96e-05	0.00017	CcSEcCtD
Lomefloxacin—Headache—Phenytoin—epilepsy syndrome	3.96e-05	0.00017	CcSEcCtD
Lomefloxacin—Discomfort—Gabapentin—epilepsy syndrome	3.96e-05	0.00017	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.95e-05	0.00206	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.95e-05	0.00206	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.95e-05	0.00206	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.95e-05	0.00206	CbGpPWpGaD
Lomefloxacin—Headache—Oxcarbazepine—epilepsy syndrome	3.94e-05	0.000169	CcSEcCtD
Lomefloxacin—Nausea—Zonisamide—epilepsy syndrome	3.93e-05	0.000169	CcSEcCtD
Lomefloxacin—Dry mouth—Gabapentin—epilepsy syndrome	3.92e-05	0.000169	CcSEcCtD
Lomefloxacin—Hypotension—Pregabalin—epilepsy syndrome	3.92e-05	0.000168	CcSEcCtD
Lomefloxacin—Flatulence—Topiramate—epilepsy syndrome	3.91e-05	0.000168	CcSEcCtD
Lomefloxacin—Tension—Topiramate—epilepsy syndrome	3.89e-05	0.000167	CcSEcCtD
Lomefloxacin—Dysgeusia—Topiramate—epilepsy syndrome	3.88e-05	0.000167	CcSEcCtD
Lomefloxacin—Confusional state—Gabapentin—epilepsy syndrome	3.88e-05	0.000167	CcSEcCtD
Lomefloxacin—Dizziness—Lamotrigine—epilepsy syndrome	3.86e-05	0.000166	CcSEcCtD
Lomefloxacin—Nervousness—Topiramate—epilepsy syndrome	3.85e-05	0.000165	CcSEcCtD
Lomefloxacin—Oedema—Gabapentin—epilepsy syndrome	3.84e-05	0.000165	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.84e-05	0.000165	CcSEcCtD
Lomefloxacin—Vomiting—Carbamazepine—epilepsy syndrome	3.84e-05	0.000165	CcSEcCtD
Lomefloxacin—Back pain—Topiramate—epilepsy syndrome	3.83e-05	0.000165	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	3.83e-05	0.002	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.82e-05	0.000164	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.82e-05	0.000164	CcSEcCtD
Lomefloxacin—Muscle spasms—Topiramate—epilepsy syndrome	3.81e-05	0.000164	CcSEcCtD
Lomefloxacin—Rash—Carbamazepine—epilepsy syndrome	3.81e-05	0.000164	CcSEcCtD
Lomefloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	3.8e-05	0.000164	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.8e-05	0.00199	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.79e-05	0.000163	CcSEcCtD
Lomefloxacin—Insomnia—Pregabalin—epilepsy syndrome	3.79e-05	0.000163	CcSEcCtD
Lomefloxacin—Nausea—Clonazepam—epilepsy syndrome	3.78e-05	0.000163	CcSEcCtD
Lomefloxacin—Headache—Carbamazepine—epilepsy syndrome	3.78e-05	0.000163	CcSEcCtD
Lomefloxacin—Shock—Gabapentin—epilepsy syndrome	3.78e-05	0.000163	CcSEcCtD
Lomefloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	3.77e-05	0.000162	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.76e-05	0.000162	CcSEcCtD
Lomefloxacin—Nausea—Phenytoin—epilepsy syndrome	3.76e-05	0.000162	CcSEcCtD
Lomefloxacin—Tachycardia—Gabapentin—epilepsy syndrome	3.75e-05	0.000161	CcSEcCtD
Lomefloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	3.74e-05	0.000161	CcSEcCtD
Lomefloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	3.74e-05	0.000161	CcSEcCtD
Lomefloxacin—Skin disorder—Gabapentin—epilepsy syndrome	3.73e-05	0.000161	CcSEcCtD
Lomefloxacin—Somnolence—Pregabalin—epilepsy syndrome	3.73e-05	0.00016	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.72e-05	0.00016	CcSEcCtD
Lomefloxacin—Tremor—Topiramate—epilepsy syndrome	3.71e-05	0.00016	CcSEcCtD
Lomefloxacin—Vomiting—Lamotrigine—epilepsy syndrome	3.71e-05	0.00016	CcSEcCtD
Lomefloxacin—Urticaria—Valproic Acid—epilepsy syndrome	3.68e-05	0.000158	CcSEcCtD
Lomefloxacin—Rash—Lamotrigine—epilepsy syndrome	3.68e-05	0.000158	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Topiramate—epilepsy syndrome	3.68e-05	0.000158	CcSEcCtD
Lomefloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	3.68e-05	0.000158	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.67e-05	0.00192	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	3.67e-05	0.000158	CcSEcCtD
Lomefloxacin—Anorexia—Gabapentin—epilepsy syndrome	3.66e-05	0.000158	CcSEcCtD
Lomefloxacin—Anaemia—Topiramate—epilepsy syndrome	3.66e-05	0.000157	CcSEcCtD
Lomefloxacin—Headache—Lamotrigine—epilepsy syndrome	3.66e-05	0.000157	CcSEcCtD
Lomefloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	3.64e-05	0.000157	CcSEcCtD
Lomefloxacin—Agitation—Topiramate—epilepsy syndrome	3.64e-05	0.000157	CcSEcCtD
Lomefloxacin—Fatigue—Pregabalin—epilepsy syndrome	3.61e-05	0.000155	CcSEcCtD
Lomefloxacin—Hypotension—Gabapentin—epilepsy syndrome	3.59e-05	0.000154	CcSEcCtD
Lomefloxacin—Nausea—Carbamazepine—epilepsy syndrome	3.59e-05	0.000154	CcSEcCtD
Lomefloxacin—Constipation—Pregabalin—epilepsy syndrome	3.59e-05	0.000154	CcSEcCtD
Lomefloxacin—Malaise—Topiramate—epilepsy syndrome	3.57e-05	0.000154	CcSEcCtD
Lomefloxacin—Vertigo—Topiramate—epilepsy syndrome	3.56e-05	0.000153	CcSEcCtD
Lomefloxacin—Syncope—Topiramate—epilepsy syndrome	3.55e-05	0.000153	CcSEcCtD
Lomefloxacin—Leukopenia—Topiramate—epilepsy syndrome	3.55e-05	0.000153	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.5e-05	0.000151	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.5e-05	0.00183	CbGpPWpGaD
Lomefloxacin—Loss of consciousness—Topiramate—epilepsy syndrome	3.48e-05	0.00015	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.48e-05	0.00182	CbGpPWpGaD
Lomefloxacin—Insomnia—Gabapentin—epilepsy syndrome	3.48e-05	0.000149	CcSEcCtD
Lomefloxacin—Nausea—Lamotrigine—epilepsy syndrome	3.47e-05	0.000149	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.46e-05	0.00181	CbGpPWpGaD
Lomefloxacin—Cough—Topiramate—epilepsy syndrome	3.46e-05	0.000149	CcSEcCtD
Lomefloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	3.46e-05	0.000149	CcSEcCtD
Lomefloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	3.45e-05	0.000148	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.45e-05	0.0018	CbGpPWpGaD
Lomefloxacin—Convulsion—Topiramate—epilepsy syndrome	3.43e-05	0.000148	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.43e-05	0.000147	CcSEcCtD
Lomefloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	3.43e-05	0.000147	CcSEcCtD
Lomefloxacin—Hypertension—Topiramate—epilepsy syndrome	3.42e-05	0.000147	CcSEcCtD
Lomefloxacin—Somnolence—Gabapentin—epilepsy syndrome	3.42e-05	0.000147	CcSEcCtD
Lomefloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.42e-05	0.000147	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.39e-05	0.00177	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	3.38e-05	0.000145	CcSEcCtD
Lomefloxacin—Chest pain—Topiramate—epilepsy syndrome	3.37e-05	0.000145	CcSEcCtD
Lomefloxacin—Arthralgia—Topiramate—epilepsy syndrome	3.37e-05	0.000145	CcSEcCtD
Lomefloxacin—Myalgia—Topiramate—epilepsy syndrome	3.37e-05	0.000145	CcSEcCtD
Lomefloxacin—Anxiety—Topiramate—epilepsy syndrome	3.36e-05	0.000145	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.36e-05	0.00175	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	3.34e-05	0.000144	CcSEcCtD
Lomefloxacin—Discomfort—Topiramate—epilepsy syndrome	3.33e-05	0.000143	CcSEcCtD
Lomefloxacin—Urticaria—Pregabalin—epilepsy syndrome	3.33e-05	0.000143	CcSEcCtD
Lomefloxacin—Asthenia—Valproic Acid—epilepsy syndrome	3.33e-05	0.000143	CcSEcCtD
Lomefloxacin—Fatigue—Gabapentin—epilepsy syndrome	3.31e-05	0.000142	CcSEcCtD
Lomefloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	3.31e-05	0.000142	CcSEcCtD
Lomefloxacin—Dry mouth—Topiramate—epilepsy syndrome	3.3e-05	0.000142	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.29e-05	0.00172	CbGpPWpGaD
Lomefloxacin—Constipation—Gabapentin—epilepsy syndrome	3.29e-05	0.000141	CcSEcCtD
Lomefloxacin—Pruritus—Valproic Acid—epilepsy syndrome	3.28e-05	0.000141	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	3.27e-05	0.00171	CbGpPWpGaD
Lomefloxacin—Confusional state—Topiramate—epilepsy syndrome	3.26e-05	0.00014	CcSEcCtD
Lomefloxacin—Oedema—Topiramate—epilepsy syndrome	3.23e-05	0.000139	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.23e-05	0.00169	CbGpPWpGaD
Lomefloxacin—Shock—Topiramate—epilepsy syndrome	3.18e-05	0.000137	CcSEcCtD
Lomefloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	3.17e-05	0.000136	CcSEcCtD
Lomefloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	3.17e-05	0.000136	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	3.17e-05	0.000136	CcSEcCtD
Lomefloxacin—Tachycardia—Topiramate—epilepsy syndrome	3.16e-05	0.000136	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.14e-05	0.000135	CcSEcCtD
Lomefloxacin—Skin disorder—Topiramate—epilepsy syndrome	3.14e-05	0.000135	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	3.13e-05	0.000134	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.12e-05	0.00163	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.12e-05	0.00163	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.12e-05	0.00163	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	3.09e-05	0.000133	CcSEcCtD
Lomefloxacin—Anorexia—Topiramate—epilepsy syndrome	3.08e-05	0.000133	CcSEcCtD
Lomefloxacin—Dizziness—Valproic Acid—epilepsy syndrome	3.07e-05	0.000132	CcSEcCtD
Lomefloxacin—Urticaria—Gabapentin—epilepsy syndrome	3.05e-05	0.000131	CcSEcCtD
Lomefloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	3.04e-05	0.000131	CcSEcCtD
Lomefloxacin—Hypotension—Topiramate—epilepsy syndrome	3.02e-05	0.00013	CcSEcCtD
Lomefloxacin—Asthenia—Pregabalin—epilepsy syndrome	3.01e-05	0.000129	CcSEcCtD
Lomefloxacin—Pruritus—Pregabalin—epilepsy syndrome	2.97e-05	0.000128	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.97e-05	0.00155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.97e-05	0.00155	CbGpPWpGaD
Lomefloxacin—Vomiting—Valproic Acid—epilepsy syndrome	2.95e-05	0.000127	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.95e-05	0.000127	CcSEcCtD
Lomefloxacin—Insomnia—Topiramate—epilepsy syndrome	2.93e-05	0.000126	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—APEX1—epilepsy syndrome	2.92e-05	0.00153	CbGpPWpGaD
Lomefloxacin—Rash—Valproic Acid—epilepsy syndrome	2.92e-05	0.000126	CcSEcCtD
Lomefloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	2.92e-05	0.000126	CcSEcCtD
Lomefloxacin—Headache—Valproic Acid—epilepsy syndrome	2.91e-05	0.000125	CcSEcCtD
Lomefloxacin—Paraesthesia—Topiramate—epilepsy syndrome	2.9e-05	0.000125	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.9e-05	0.00151	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Topiramate—epilepsy syndrome	2.88e-05	0.000124	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.88e-05	0.00151	CbGpPWpGaD
Lomefloxacin—Somnolence—Topiramate—epilepsy syndrome	2.88e-05	0.000124	CcSEcCtD
Lomefloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	2.87e-05	0.000123	CcSEcCtD
Lomefloxacin—Dyspepsia—Topiramate—epilepsy syndrome	2.85e-05	0.000122	CcSEcCtD
Lomefloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.83e-05	0.000122	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.82e-05	0.00147	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Topiramate—epilepsy syndrome	2.81e-05	0.000121	CcSEcCtD
Lomefloxacin—Fatigue—Topiramate—epilepsy syndrome	2.79e-05	0.00012	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.78e-05	0.00145	CbGpPWpGaD
Lomefloxacin—Dizziness—Pregabalin—epilepsy syndrome	2.77e-05	0.000119	CcSEcCtD
Lomefloxacin—Constipation—Topiramate—epilepsy syndrome	2.77e-05	0.000119	CcSEcCtD
Lomefloxacin—Asthenia—Gabapentin—epilepsy syndrome	2.76e-05	0.000119	CcSEcCtD
Lomefloxacin—Nausea—Valproic Acid—epilepsy syndrome	2.75e-05	0.000118	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.75e-05	0.00144	CbGpPWpGaD
Lomefloxacin—Pruritus—Gabapentin—epilepsy syndrome	2.72e-05	0.000117	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—epilepsy syndrome	2.7e-05	0.00141	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.67e-05	0.0014	CbGpPWpGaD
Lomefloxacin—Vomiting—Pregabalin—epilepsy syndrome	2.67e-05	0.000115	CcSEcCtD
Lomefloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	2.67e-05	0.000115	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.65e-05	0.000114	CcSEcCtD
Lomefloxacin—Rash—Pregabalin—epilepsy syndrome	2.64e-05	0.000114	CcSEcCtD
Lomefloxacin—Dermatitis—Pregabalin—epilepsy syndrome	2.64e-05	0.000114	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.64e-05	0.00138	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	2.63e-05	0.000113	CcSEcCtD
Lomefloxacin—Headache—Pregabalin—epilepsy syndrome	2.63e-05	0.000113	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	2.61e-05	0.00137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.6e-05	0.00136	CbGpPWpGaD
Lomefloxacin—Urticaria—Topiramate—epilepsy syndrome	2.57e-05	0.00011	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	2.57e-05	0.00134	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Topiramate—epilepsy syndrome	2.56e-05	0.00011	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	2.55e-05	0.00133	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.54e-05	0.00133	CbGpPWpGaD
Lomefloxacin—Dizziness—Gabapentin—epilepsy syndrome	2.54e-05	0.000109	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	2.53e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.53e-05	0.00132	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.51e-05	0.00131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.5e-05	0.0013	CbGpPWpGaD
Lomefloxacin—Nausea—Pregabalin—epilepsy syndrome	2.49e-05	0.000107	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.48e-05	0.00129	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.46e-05	0.00128	CbGpPWpGaD
Lomefloxacin—Vomiting—Gabapentin—epilepsy syndrome	2.44e-05	0.000105	CcSEcCtD
Lomefloxacin—Rash—Gabapentin—epilepsy syndrome	2.42e-05	0.000104	CcSEcCtD
Lomefloxacin—Dermatitis—Gabapentin—epilepsy syndrome	2.42e-05	0.000104	CcSEcCtD
Lomefloxacin—Headache—Gabapentin—epilepsy syndrome	2.41e-05	0.000104	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.4e-05	0.00125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.39e-05	0.00125	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	2.38e-05	0.000102	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—H2AFX—epilepsy syndrome	2.34e-05	0.00122	CbGpPWpGaD
Lomefloxacin—Asthenia—Topiramate—epilepsy syndrome	2.32e-05	9.98e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	2.31e-05	0.00121	CbGpPWpGaD
Lomefloxacin—Pruritus—Topiramate—epilepsy syndrome	2.29e-05	9.84e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	2.29e-05	0.00119	CbGpPWpGaD
Lomefloxacin—Nausea—Gabapentin—epilepsy syndrome	2.28e-05	9.82e-05	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.26e-05	0.00118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.25e-05	0.00118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.25e-05	0.00117	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.24e-05	0.00117	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Topiramate—epilepsy syndrome	2.21e-05	9.51e-05	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.17e-05	0.00113	CbGpPWpGaD
Lomefloxacin—Dizziness—Topiramate—epilepsy syndrome	2.14e-05	9.19e-05	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.11e-05	0.0011	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.11e-05	0.0011	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.11e-05	0.0011	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	2.08e-05	0.00109	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	2.07e-05	0.00108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.07e-05	0.00108	CbGpPWpGaD
Lomefloxacin—Vomiting—Topiramate—epilepsy syndrome	2.06e-05	8.84e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.06e-05	0.00107	CbGpPWpGaD
Lomefloxacin—Rash—Topiramate—epilepsy syndrome	2.04e-05	8.77e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Topiramate—epilepsy syndrome	2.04e-05	8.76e-05	CcSEcCtD
Lomefloxacin—Headache—Topiramate—epilepsy syndrome	2.03e-05	8.71e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.02e-05	0.00105	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.01e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.98e-05	0.00103	CbGpPWpGaD
Lomefloxacin—Nausea—Topiramate—epilepsy syndrome	1.92e-05	8.26e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—ATM—epilepsy syndrome	1.9e-05	0.000992	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PRKCB—epilepsy syndrome	1.86e-05	0.000972	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.8e-05	0.000938	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.74e-05	0.00091	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.73e-05	0.000904	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.73e-05	0.000904	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.65e-05	0.000864	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.64e-05	0.000856	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.59e-05	0.000829	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.57e-05	0.00082	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.4e-05	0.000732	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.36e-05	0.000709	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.32e-05	0.00069	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.21e-05	0.000631	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.21e-05	0.000631	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.21e-05	0.000631	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.21e-05	0.000631	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.12e-05	0.000586	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.12e-05	0.000586	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.12e-05	0.000585	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.06e-05	0.000551	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1e-05	0.000523	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1e-05	0.000523	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1e-05	0.000523	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1e-05	0.000523	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1e-05	0.000523	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.93e-06	0.000518	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.79e-06	0.000511	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.72e-06	0.000508	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UPB1—epilepsy syndrome	9.16e-06	0.000478	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ATIC—epilepsy syndrome	9.16e-06	0.000478	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NEU1—epilepsy syndrome	9.16e-06	0.000478	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	8.81e-06	0.00046	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	8.51e-06	0.000444	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	8.51e-06	0.000444	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.32e-06	0.000434	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8e-06	0.000418	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	7.79e-06	0.000406	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	7.59e-06	0.000396	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	7.59e-06	0.000396	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	7.24e-06	0.000378	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	7.24e-06	0.000378	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.08e-06	0.00037	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	6.94e-06	0.000362	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	6.81e-06	0.000355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	6.68e-06	0.000349	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.25e-06	0.000326	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.07e-06	0.000317	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.83e-06	0.000304	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	5.49e-06	0.000286	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	5.49e-06	0.000286	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.11e-06	0.000267	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.01e-06	0.000261	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.47e-06	0.000233	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.36e-06	0.000228	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.33e-06	0.000226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.3e-06	0.000224	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.92e-06	0.000205	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.91e-06	0.000204	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.72e-06	0.000194	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.71e-06	0.000193	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.53e-06	0.000185	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.5e-06	0.000183	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TH—epilepsy syndrome	3.48e-06	0.000182	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.43e-06	0.000179	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.91e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.87e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.79e-06	0.000146	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.59e-06	0.000135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.28e-06	0.000119	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.23e-06	0.000116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.91e-06	0.0001	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.75e-06	9.11e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	7.97e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	7.68e-07	4.01e-05	CbGpPWpGaD
